 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||||||| acetaminophen/naproxen / J&J
Trial completion: A Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen and Naproxen Sodium in Postoperative Dental Pain (clinicaltrials.gov) - Jun 21, 2024
P3, N=447, Completed, Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
Recruiting --> Completed
- ||||| acetaminophen/naproxen / J&J
Trial completion: A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy (clinicaltrials.gov) - Jun 11, 2024
P3, N=122, Completed, Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
Recruiting --> Completed Recruiting --> Completed
- || acetaminophen/naproxen / J&J
Trial completion: A Study of Acetaminophen/Naproxen Sodium Fixed Combination Tablets in Adolescents 12 to <17 Years of Age With Pain (clinicaltrials.gov) - Mar 15, 2024
P1, N=24, Completed, Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
Recruiting --> Completed Recruiting --> Completed
- || acetaminophen/naproxen / J&J
Enrollment change, Trial withdrawal: A Multiple-Dose Safety Study of Fixed Combination of Acetaminophen/Naproxen Sodium in Adolescents With Orthodontic Pain (clinicaltrials.gov) - Mar 5, 2024
P3, N=0, Withdrawn, Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
Recruiting --> Completed N=75 --> 0 | Not yet recruiting --> Withdrawn
- |||| acetaminophen/naproxen / J&J
Trial completion date, Trial initiation date, Trial primary completion date: A Multiple-Dose Safety Study of Fixed Combination of Acetaminophen/Naproxen Sodium in Adolescents With Orthodontic Pain (clinicaltrials.gov) - Oct 19, 2023
P3, N=75, Not yet recruiting, Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
N=75 --> 0 | Not yet recruiting --> Withdrawn Trial completion date: Mar 2024 --> Jul 2024 | Initiation date: Sep 2023 --> Jan 2024 | Trial primary completion date: Mar 2024 --> Jul 2024
- || acetaminophen/naproxen / J&J
Enrollment open: A Study of Acetaminophen/Naproxen Sodium Fixed Combination Tablets in Adolescents 12 to <17 Years of Age With Pain (clinicaltrials.gov) - Oct 12, 2023
P1, N=30, Recruiting, Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
Trial completion date: Mar 2024 --> Jul 2024 | Initiation date: Sep 2023 --> Jan 2024 | Trial primary completion date: Mar 2024 --> Jul 2024 Not yet recruiting --> Recruiting
- || acetaminophen/naproxen / J&J
Trial completion date: A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy (clinicaltrials.gov) - Oct 12, 2023
P3, N=120, Recruiting, Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
Not yet recruiting --> Recruiting Trial completion date: Sep 2024 --> Mar 2024
- |||| acetaminophen/naproxen / J&J
Enrollment open: A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy (clinicaltrials.gov) - Sep 21, 2023
P3, N=120, Recruiting, Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
Trial completion date: Sep 2024 --> Mar 2024 Not yet recruiting --> Recruiting
- |||||| acetaminophen/naproxen / J&J
Enrollment open: A Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen and Naproxen Sodium in Postoperative Dental Pain (clinicaltrials.gov) - Jun 1, 2023
P3, N=440, Recruiting, Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- |||||||| acetaminophen/naproxen / J&J
New P3 trial: A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy (clinicaltrials.gov) - May 22, 2023
P3, N=120, Not yet recruiting, Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
- |||||||| acetaminophen/naproxen / J&J
New P3 trial: A Multiple-Dose Safety Study of Fixed Combination of Acetaminophen/Naproxen Sodium in Adolescents With Orthodontic Pain (clinicaltrials.gov) - May 6, 2023
P3, N=75, Not yet recruiting, Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
- || acetaminophen/naproxen / J&J
New P1 trial: A Study of Acetaminophen/Naproxen Sodium Fixed Combination Tablets in Adolescents 12 to <17 Years of Age With Pain (clinicaltrials.gov) - May 6, 2023
P1, N=30, Not yet recruiting, Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
- |||||||||| acetaminophen/naproxen / J&J
New P3 trial: A Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen and Naproxen Sodium in Postoperative Dental Pain (clinicaltrials.gov) - Mar 9, 2023
P3, N=440, Not yet recruiting, Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
- acetaminophen/naproxen / J&J
Proof of Concept Study Evaluating the Relative Efficacy and Safety of Concomitant Acetaminophen-Naproxen Sodium versus Acetaminophen/Hydrocodone and Naproxen in Postoperative Dental Pain () - Sep 15, 2021 - Abstract #PAINWeek2021PAINWeek_69;
Onset of pain relief was similarly rapid for both ACET-NAP dose combinations and ACET650/HYD10. Both ACET-NAP dose combinations provided superior analgesia through 0-6 hours versus ACET650/HYD10.
- |||| acetaminophen/naproxen / J&J
Trial completion, Trial completion date, Trial primary completion date: Acetaminophen/Naproxen Sodium Dose Ranging Study (clinicaltrials.gov) - Jun 9, 2021
P2, N=304, Completed, Sponsor: Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division
Both ACET-NAP dose combinations provided superior analgesia through 0-6 hours versus ACET650/HYD10. Enrolling by invitation --> Completed | Trial completion date: Aug 2021 --> May 2021 | Trial primary completion date: Jul 2021 --> Apr 2021
- | acetaminophen/naproxen / J&J
Enrollment open: Acetaminophen/Naproxen Sodium Dose Ranging Study (clinicaltrials.gov) - Dec 20, 2020
P2, N=300, Enrolling by invitation, Sponsor: Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division
Enrolling by invitation --> Completed | Trial completion date: Aug 2021 --> May 2021 | Trial primary completion date: Jul 2021 --> Apr 2021 Not yet recruiting --> Enrolling by invitation
- | acetaminophen/naproxen / J&J
New P2 trial: Acetaminophen/Naproxen Sodium Dose Ranging Study (clinicaltrials.gov) - Jun 25, 2020
P2, N=300, Not yet recruiting, Sponsor: Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division